Following are comments from firms on their China business during the latest reporting season:
Procter & Gamble: The Tide detergent maker reported an overall volumes fall of 1% in its fourth quarter, mainly due to weaker demand in the Greater China region.
Intel: “The China market, I think, has been well reported, hasn’t come back as strongly as people would have expected overall,” said Intel CEO Pat Gelsinger.
AbbVie Inc The Botox maker said it has seen rates for aesthetics treatments in China fully recover to pre-COVID levels and continues to anticipate strong growth through the rest of the year in the country.
Mastercard Inbound cross-border travel to China stood at nearly 50% of 2019 levels, while outbound travel was nearly 70%, the company said.
Anglo American The global miner said it has been surprised by how slow the reopening of China has been but believed a recovery was underway.
L’Oreal The Chinese market is “really picking up,” although “not at the speed everybody had hoped for,” L’Oreal CEO Nicolas Hieronimus told Reuters.
Mobileye Global Saw weak demand for its driver-assistance technology in China.
Coca-Cola The company saw strong demand for some juice business in China but also flagged destocking activity in the second quarter.
Seagate The computer hardware maker said its fourth-quarter Technology performance was impacted due to the uneven pace of the Chinese economic recovery.
LG Energy Company warned it faces weaker EV demand in China than Solution previously expected.
Thermo Fisher The company witnessed significantly slower economic activity Scientific in China during the second quarter. “We think it’s appropriate to assume that this condition remains in place for the remainder of the year,” said CFO Stephen Williamson.
Visa “Looking at Mainland China specifically, cross-border travel continued to improve but remains well below 2019 levels,” CFO Vasant Prabhu said.
LVMH The French luxury giant logged a strong rebound in China during the second quarter.
3M Co The industrial conglomerate flagged continued weak appetite for consumer electronics demand in China.
GE Healthcare The company saw improved demand for medical equipment in the region in the recent quarter and that is expected to continue as China prioritizes improved healthcare access following the end of the pandemic.
Dow Inc The chemical maker said the anticipated rebound following the end of pandemic curbs has yet to fully materialize.
EssilorLuxottica The luxury eyewear maker continued to benefit from a recovery in China during the second quarter.
NXP The chipmaker said China’s export curbs on certain gallium semiconductors and germanium products did not impact the company.
ABB The engineering firm witnessed fewer new orders from China in the quarter and said some customers were shifting investments to other parts of Asia due to geopolitical tensions.
Citigroup The lender called it the “biggest disappointment” as growth decelerated after an initial post-reopening pop.